Stem definition | Drug id | CAS RN |
---|---|---|
beta3-adrenoreceptor agonists | 5311 | 1190389-15-1 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 23, 2020 | FDA | UROVANT SCIENCES GMBH | |
Sept. 21, 2018 | PMDA | Kyorin Pharmaceutical Co., Ltd. |
None
None
None
None
Source | Code | Description |
---|---|---|
CHEBI has role | CHEBI:35522 | beta-adrenergic agonists |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Bladder muscle dysfunction - overactive | indication | 236633002 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 13.78 | acidic |
pKa2 | 8.94 | Basic |
pKa3 | 2.54 | Basic |
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Patent number | Patent expiration date | Patent use |
---|---|---|---|---|---|---|---|---|---|---|
75MG | GEMTESA | UROVANT | N213006 | Dec. 23, 2020 | RX | TABLET | ORAL | 8247415 | Dec. 1, 2030 | TREATMENT OF OVERACTIVE BLADDER (OAB) WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY, AND URINARY FREQUENCY |
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Exclusivity date | Description |
---|---|---|---|---|---|---|---|---|---|
75MG | GEMTESA | UROVANT | N213006 | Dec. 23, 2020 | RX | TABLET | ORAL | Dec. 23, 2025 | NEW CHEMICAL ENTITY |
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Beta-3 adrenergic receptor | GPCR | AGONIST | EC50 | 8.96 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
Beta-3 adrenergic receptor | GPCR | EC50 | 7.07 | CHEMBL | |||||
Beta-3 adrenergic receptor | GPCR | EC50 | 7.96 | CHEMBL | |||||
Beta-3 adrenergic receptor | GPCR | EC50 | 9.24 | CHEMBL |
ID | Source |
---|---|
M5TSE03W5U | UNII |
C4279743 | UMLSCUI |
CHEBI:142418 | CHEBI |
CHEMBL2107826 | ChEMBL_ID |
44472635 | PUBCHEM_CID |
DB14895 | DRUGBANK_ID |
D10433 | KEGG_DRUG |
9676 | INN_ID |
10100 | IUPHAR_LIGAND_ID |
39113 | MMSL |
d09697 | MMSL |
018600 | NDDF |
1149377005 | SNOMEDCT_US |
1149380006 | SNOMEDCT_US |
4039964 | VANDF |
C000608232 | MESH_SUPPLEMENTAL_RECORD_UI |
2472254 | RXNORM |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
GEMTESA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 73336-075 | TABLET, FILM COATED | 75 mg | ORAL | NDA | 31 sections |